ArticleOncology letters2023

Efficacy, toxicity and prognostic factors of pyrotinib‑involved neoadjuvant therapy in HER2‑positive breast cancer: A retrospective study.

Hao Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.